Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M158Revenue $M0.2Net Margin (%)0Z-Score4.6
Enterprise Value $M105EPS $-0.6Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %0Quick Ratio13.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-24.6Current Ratio13.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-46.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-51.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.8ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ONTY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTYGeorge Soros 2014-06-30 Sold Out $2.35 - $3.5
($2.94)
$ 2.17-26%Sold Out0
ONTYGeorge Soros 2014-03-31 Buy $1.71 - $3.89
($2.7)
$ 2.17-20%New holding, 89600 sh.89,600
ONTYJean-Marie Eveillard 2013-09-30 Add0.01%$1.59 - $2.18
($1.75)
$ 2.1724%Add 75.63%2,275,287
ONTYJean-Marie Eveillard 2013-06-30 Add0.01%$1.57 - $2.63
($2.14)
$ 2.171%Add 547.75%1,295,499
ONTYJean-Marie Eveillard 2013-03-31 Buy $1.86 - $2.35
($2.09)
$ 2.174%New holding, 200000 sh.200,000
ONTYJean-Marie Eveillard 2012-03-31 Sold Out -0.0033%$4.16 - $8.96
($6.31)
$ 2.17-66%Sold Out0
ONTYJean-Marie Eveillard 2011-12-31 Add$5.84 - $8.25
($6.85)
$ 2.17-68%Add 33.33%100,000
ONTYJean-Marie Eveillard 2011-09-30 Reduce-0.01%$5.95 - $10.2
($7.49)
$ 2.17-71%Reduce -66.67%75,000
ONTYJean-Marie Eveillard 2011-06-30 Buy 0.01%$3.8 - $9.43
($5.79)
$ 2.17-62%New holding, 225000 sh.225,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ONTY Jean-Marie Eveillard 2014-06-302,384,0393.370.02-12.51%
ONTY George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ONTY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BVF PARTNERS L P/IL10% Owner 2013-11-01Buy129,000$1.7821.91view
BVF PARTNERS L P/IL10% Owner 2013-08-08Buy258,361$1.6531.52view
BVF PARTNERS L P/IL10% Owner 2013-08-01Buy338,087$1.7424.71view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy214,467$1.8119.89view
Ayer Capital Management, LP10% Owner 2011-06-23Sell28,900$8.74-75.17view
Karan Shashi K.Corporate Controller 2010-09-28Buy5,100$3.41-36.36view
Karan Shashi K.Corporate Controller 2009-08-18Buy5,000$5.07-57.2view

Press Releases about ONTY :

    Quarterly/Annual Reports about ONTY:

    News about ONTY:

    Articles On GuruFocus.com
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    pro-longs life Jul 30 2011 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    cooldecency99 note on ONTY May 01 2010 
    creiter note on ONTY Jan 03 2010 

    More From Our Partners
    Events for the Week of Sept. 8-12 Sep 10 2014 - BENZINGA

    More From Other Websites
    ONCOTHYREON INC. Files SEC form 8-K, Other Events Sep 12 2014
    Oncothyreon to Present at Rodman & Renshaw Global Investment Conference Sep 02 2014
    Why You Shouldn't Bet Against Oncothyreon (ONTY) Stock Aug 28 2014
    Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study Aug 20 2014
    Oncothyreon (ONTY) is Oversold: Can It Recover? Aug 20 2014
    Oncothyreon Plunges On Drug Fail; Wedbush Slashes Price Target Aug 19 2014
    Why Oncothyreon (ONTY) Stock Is Plunging Today Aug 19 2014
    ONCOTHYREON INC. Financials Aug 19 2014
    ONCOTHYREON INC. Files SEC form 8-K, Other Events Aug 18 2014
    ONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Aug 11 2014
    Oncothyreon Reports Second Quarter 2014 Financial Results Aug 11 2014
    Oncothyreon Announces Acquisition of Alpine Biosciences Aug 11 2014
    Oncothyreon Announces Second Quarter 2014 Financial Results Conference Call Aug 04 2014
    ONCOTHYREON INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jun 10 2014
    Can the Rally in Oncothyreon (ONTY) Shares Continue? Jun 06 2014
    ONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Jun 02 2014
    Oncothyreon Announces Presentation of ONT-10 Data at ASCO Annual Meeting Jun 02 2014
    Oncothyreon Collaborates with Celldex May 30 2014
    Oncothyreon and Celldex to collaborate for clinical trial of ONT-10 and Varlilum May 29 2014
    Oncothyreon and Celldex Therapeutics Announce Collaboration for Combination Immunotherapy Clinical... May 29 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK